OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

Tissue Total RNA, Colon: right

Be the first to review this product
SKU
CR561163
RNA (5 µg); Colon: right; Adenocarcinoma of colon, mucinous
  $370.00
3 Days*

Frequently Bought Together (3)

HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
HCRT103 24 matched pairs (48 samples) covering 24-normal, 5-Stage I, 5-IIA, 2-IIB, 2-IIIA, 3-IIIB, 2-IIIC, 1-III, 4-IV. Available in 2, 5, 10 identical plates.
2 Panels
$1,060.00
Specifications
Specifications
Product Data
Disease State Cancer
Diagnosis Category Colorectal Cancer
Sample ID FR0002201B
Case ID CI0000007601
Prep 3
Vial ID RN0000167F
Tissue of Origin Colon: right
Site of Finding Colon: right
Appearance Tumor
Sample Diagnosis (from Pathology Verification) Adenocarcinoma of colon, mucinous
Normal 0%
Lesional 0%
Tumor 80%
Tumor Hypo/Acellular Stroma 10%
Tumor Hypercellular Stroma 10%
Necrosis 0%
T (Extent of Primary Tumor) T3
N (Lymph node metastasis) N0
M (Distant metastasis) MX
CASE Diagnosis (from medical center path report) Adenocarcinoma of colon, mucinous
Age 69
Gender Female
Tumor Grade Not Reported
Minimum Stage Grouping IIA
Storage Store tissue total RNA at -80°C.
Stability These products are stable for one year from date of shipping when stored at -80°C without repeated freeze/thaws.
Shipping Dry Ice
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
Ragulan, Eason, Fontana et al
Sci Rep (2019) 9 (1), 7665 DOI: 10.1038/s41598-019-43492-0
AI Summary: OriGene contributed to this study by providing a cohort of 17 colorectal cancer RNA samples ("RNA samples (OriGene; n = 17)") that were used to validate the NanoCRCA biomarker assay for molecular subtyping.
Snippet: and FFPE. The first included RNA samples from 17 stage IV patients (Montpellier cohort) from a published study 4 . A second cohort of RNA samples (OriGene;n = 17) was purchased from OriGene (Rockville, MD, USA). A third
A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes
Ragulan, Eason, Nyamundanda et al
bioRxiv (2017)
Snippet: GEO accession GSE101588. As an additional cohort (OriGene) is commercially available total RNA from 16 primary CRC tumours and 1 liver metastasis purchased from OriGene ... cohorts (Montpellier and OriGene;see Materials & Methods;Table S2a). The distribution ... Cite SaveSaving
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products